Status:
UNKNOWN
Effect of Cryoneurolysis on Pain in Patients With Hand Contracture.
Lead Sponsor:
Vancouver Island Health Authority
Conditions:
Contracture
Spasticity, Muscle
Eligibility:
All Genders
18+ years
Brief Summary
Contracture which is defined as a limitation of the maximum passive range of motion due to changes in periarticular soft tissue can contributes to severe pain and increased disabilities. Once contract...
Detailed Description
Contracture is defined as a limitation of the maximum passive range of motion of a joint due to shortening and changes of periarticular soft tissue structures. Contracture contributes to severe pain, ...
Eligibility Criteria
Inclusion
- Adult patients(at least 18 years old).
- Severe claw hand with less than 4 cm distance between the pulp of the fingers and palm of the hand.
- MAS\>= 3 in wrist and hand muscles interfering with function or causing a clinical problem, due to any neurological condition.
- Have refractory pain in wrist and hand areas with no response to the usual pain management methods including oral medication or botulinum toxin injection.
- Patients are already candidate for cryoneurolysis to manage the pain and spasticity in their hand and wrist, based on their response to diagnostic nerve block test (DNB).
- Ability to attend testing sessions, comply with testing protocols and provide written informed consent. For patients who physically are not able to complete the consent process, a witness may be asked to sign and confirm their willing for participation. Legal representative may be asked to help with consent process for participants who cognitively are not able to consent on their behalf.
Exclusion
- Have undergone any previous peripheral nerve procedures in their affected side, for the treatment of spasticity, including previous cryoneurolysis, chemical neurolysis, neurectomy or arthroplasty.
- Patients who received botulinum toxin in past 4 months in the same targeted muscles for cryoneurolysis, however, they may enter the study at the 4-month mark.
Key Trial Info
Start Date :
January 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06051656
Start Date
January 9 2023
End Date
September 1 2024
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria General Hospital
Victoria, British Columbia, Canada, V8Z 6R5